⌘K
Loading ticker…
Vaxcyte, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Vaxcyte, Inc. Common Stock (PCVX) has a 3-month relative strength percentile of 47 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 60. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.5%, relative volume 5.80×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
47 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
PCVX is in a stage 2 uptrend, week 1. Currently in a 84-day base; basing ADR 4.4% (broad 4.9%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 6.8% / 14.0%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
PCVX is held by 7 ETFs as of Mar 2026. Top owner: VTI at 0.01% weight, $266M notional. Top 3 carry $636M.
Top 7 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.01% | $266M |
| VBVanguard Small Cap ETF | 0.12% | $193M |
| IWMiShares Russell 2000 ETF | 0.25% | $176M |
| VBKVanguard Small-Cap Growth ETF | 0.28% | $108M |
| XBIState Street SPDR S&P Biotech ETF | 1.15% | $86M |
| VXFVanguard Extended Market ETF | 0.10% | $83M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.01% | $10M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PCVX Jan avg: 8.08% median: 10.81% win: 75% σ: 9.64% n: 4 2022-04-12 → 2026-05-29 | PCVX Feb avg: -2.09% median: -3.15% win: 50% σ: 14.37% n: 4 2022-04-12 → 2026-05-29 | PCVX Mar avg: -17.54% median: -7.99% win: 0% σ: 20.53% n: 4 2022-04-12 → 2026-05-29 | PCVX Apr avg: -1.20% median: -2.34% win: 20% σ: 9.48% n: 5 2022-04-12 → 2026-05-29 | PCVX May avg: 2.24% median: -0.91% win: 40% σ: 12.93% n: 5 2022-04-12 → 2026-05-29 | PCVX Jun avg: -0.23% median: 0.46% win: 75% σ: 6.89% n: 4 2022-04-12 → 2026-05-29 (current) | PCVX Jul avg: 2.80% median: 4.45% win: 75% σ: 4.44% n: 4 2022-04-12 → 2026-05-29 | PCVX Aug avg: 3.61% median: 5.20% win: 75% σ: 9.71% n: 4 2022-04-12 → 2026-05-29 | PCVX Sep avg: 12.10% median: 7.59% win: 50% σ: 22.33% n: 4 2022-04-12 → 2026-05-29 | PCVX Oct avg: 23.71% median: 10.03% win: 50% σ: 41.51% n: 4 2022-04-12 → 2026-05-29 | PCVX Nov avg: 2.88% median: 6.62% win: 75% σ: 9.59% n: 4 2022-04-12 → 2026-05-29 | PCVX Dec avg: 1.30% median: -1.45% win: 50% σ: 15.14% n: 4 2022-04-12 → 2026-05-29 |